Theriva Biologics (TOVX) Operating Leases (2019 - 2026)
Theriva Biologics (TOVX) reported Operating Leases of $1.37 million for Q2 2026, up 135.3% from $584,000 a year earlier but down 9.7% from the prior quarter.
Powered by 
Analysis
Theriva Biologics (TOVX) Operating Leases (2019 - 2026) Analysis & Trends
At the end of FY2025, Theriva Biologics posted Operating Leases of $352,000, down 59.7% from FY2024.
- Operating Leases has a five-year compound annual growth rate of 13.6% (FY2020 to FY2025).
- By year, Operating Leases came in at $873,000 in FY2024 (-39.5%), $1.44 million in FY2023 (+21.5%), $1.19 million in FY2022 (-15.4%) and $1.4 million in FY2021 (+654.3%).
- Five-year quarterly Operating Leases spans a low of $352,000 in Q4 2025 and a high of $1.8 million in Q1 2023.
- Year over year, Operating Leases gained in two of the last eight quarters, with an average decline of 5.1%.
- The high point for year-over-year Operating Leases in five years was Q4 2021 (growth of 654.3%); the low point was Q4 2025 (a decline of 59.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.52 million (Q1 2026), $352,000 (Q4 2025) and $433,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Theriva Biologics | 10.10 Mn | 10.10 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.37 Mn |
| Mar 31, 2026 | 1.52 Mn |
| Dec 31, 2025 | 352,000.00 |
| Sep 30, 2025 | 433,000.00 |
| Jun 30, 2025 | 584,000.00 |
| Mar 31, 2025 | 732,000.00 |
| Dec 31, 2024 | 873,000.00 |
| Sep 30, 2024 | 1.04 Mn |
| Jun 30, 2024 | 1.16 Mn |
| Mar 31, 2024 | 1.30 Mn |
| Dec 31, 2023 | 1.44 Mn |
| Sep 30, 2023 | 1.55 Mn |
| Jun 30, 2023 | 1.68 Mn |
| Mar 31, 2023 | 1.80 Mn |
| Dec 31, 2022 | 1.19 Mn |
| Sep 30, 2022 | 1.24 Mn |
| Jun 30, 2022 | 1.30 Mn |
| Mar 31, 2022 | 1.35 Mn |
| Dec 31, 2021 | 1.40 Mn |
| Sep 30, 2021 | 1.40 Mn |
API Access
Theriva Biologics Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=TOVX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "TOVX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=TOVX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();